RELAY THERAPEUTICS INC (RLAY) Stock Balance Sheet
NASDAQ:RLAY - Nasdaq - US75943R1023 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 93.54M | 124.29M | 143.74M | 151.80M | 280.10M | |||
| Marketable Securities | 616.81M | 657.04M | 606.35M | 847.10M | 678.00M | |||
| Receivables | N/A | N/A | 0.00 | 5.20M | 4.90M | |||
| Other Current Assets | 29.30M | 27.88M | 20.02M | 15.40M | 13.20M | |||
| Total Current Assets | 739.66M | 809.20M | 770.10M | 1.02B | 976.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 55.28M | 57.67M | 68.87M | 75.40M | 27.30M | |||
| Intangibles | 2.30M | 2.30M | 2.30M | 2.30M | 2.30M | |||
| Other Non-Current Assets | 2.12M | 2.12M | 2.71M | 2.60M | 2.60M | |||
| Total Non-Current Assets | 59.70M | 62.09M | 73.88M | 80.30M | 32.20M | |||
| TOTAL ASSETS | 799.36M | 871.30M | 843.98M | 1.10B | 1.01B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 26.92M | 26.33M | 19.06M | 25.40M | 15.20M | |||
| Accounts Payable | 8.45M | 14.10M | 9.21M | 10.60M | 8.30M | |||
| Other Current Liabilities | 1.68M | 10.30M | 2.00M | 27.70M | 800.00K | |||
| Total Current Liabilities | 37.05M | 50.73M | 30.27M | 63.70M | 24.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 41.23M | 42.77M | 61.71M | 85.80M | 86.30M | |||
| Total Non-Current Liabilities | 41.23M | 42.77M | 61.71M | 85.90M | 86.30M | |||
| TOTAL LIABILITIES | 78.28M | 93.50M | 91.98M | 149.60M | 110.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.82B | -1.74B | -1.40B | -1.06B | -768.10M | |||
| Additional Paid In Capital | 2.54B | 2.52B | 2.15B | 2.02B | 1.67B | |||
| Common Shares | 168.00K | 168.00K | 127.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 38.00K | -991.00K | -196.00K | -10.40M | -1.10M | |||
| Shares Outstanding | 170.48M | 167.76M | 127.46M | 121.10M | 108.20M | |||
| Tangible Book Value per Share | 4.22 | 4.62 | 5.88 | 7.83 | 8.28 | |||
| Total Shareholders' Equity | 721.08M | 777.79M | 752.00M | 950.20M | 897.80M | |||
| TOTAL LIABILITIES AND EQUITY | 799.36M | 871.30M | 843.98M | 1.10B | 1.01B | |||
| Statistics | ||||||||
| Current Ratio | 19.96 | 15.95 | 25.44 | 16.00 | 40.17 | |||
| Return On Assets (ROA) | -41.71% | -38.76% | -40.52% | -26.41% | -36.08% | |||
| Return On Equity (ROE) | -46.23% | -43.42% | -45.47% | -30.57% | -40.53% | |||
All data in USD , ROIC based on taxRate of 0.21